HC Wainwright Reiterates “Buy” Rating for Palatin Technologies (NYSEAMERICAN:PTN)
HC Wainwright reaffirmed their buy rating on shares of Palatin Technologies (NYSEAMERICAN:PTN – Free Report) in a research report sent to investors on Wednesday morning, Benzinga reports. HC Wainwright currently has a $17.00 price objective on the biopharmaceutical company’s stock. Palatin Technologies Price Performance Shares of NYSEAMERICAN PTN opened at $1.63 on Wednesday. Palatin Technologies […]
More Stories
Keyence Co. (OTCMKTS:KYCCF) Sees Significant Decrease in Short Interest
Keyence Co. (OTCMKTS:KYCCF – Get Free Report) was the target of a large drop in short interest during the month...
EnLink Midstream (NYSE:ENLC) Lowered to “Equal Weight” at Morgan Stanley
Morgan Stanley cut shares of EnLink Midstream (NYSE:ENLC – Free Report) from an overweight rating to an equal weight rating...
HC Wainwright Reaffirms “Buy” Rating for CG Oncology (NASDAQ:CGON)
HC Wainwright reiterated their buy rating on shares of CG Oncology (NASDAQ:CGON – Free Report) in a research note released...
DMC Global (NASDAQ:BOOM) PT Lowered to $17.00 at Stifel Nicolaus
DMC Global (NASDAQ:BOOM – Free Report) had its target price decreased by Stifel Nicolaus from $19.00 to $17.00 in a...
Cellectar Biosciences (NASDAQ:CLRB) Upgraded at StockNews.com
StockNews.com upgraded shares of Cellectar Biosciences (NASDAQ:CLRB – Free Report) to a sell rating in a research report sent to...
Conn’s (NASDAQ:CONN) Research Coverage Started at StockNews.com
StockNews.com started coverage on shares of Conn’s (NASDAQ:CONN – Free Report) in a research note released on Tuesday morning. The...